American Oncology Network, Inc. (NASDAQ:AONC) Sees Significant Decline in Short Interest

American Oncology Network, Inc. (NASDAQ:AONC) saw a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 23,100 shares, a decrease of 9.8% from the March 31st total of 25,600 shares. Based on an average daily volume of 9,700 shares, the short-interest ratio is presently 2.4 days. Currently, 0.8% of the company’s stock are short sold.

Hedge Funds Weigh In On American Oncology Network

A hedge fund recently bought a new stake in American Oncology Network stock. Applied Capital LLC purchased a new position in shares of American Oncology Network, Inc. (NASDAQ:AONC) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 37,499 shares of the company’s stock, valued at approximately $221,000.

American Oncology Network Stock Performance

Shares of AONC opened at $4.38 on Tuesday. The firm’s fifty day simple moving average is $5.52 and its 200-day simple moving average is $5.92. American Oncology Network has a twelve month low of $3.80 and a twelve month high of $39.60.

About American Oncology Network

American Oncology Network, Inc, through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance.